drugset / Trial / NCT00216411

Effects on Quality of Life Following Dysport Treatment in Post-stroke Spasticity of the Arm

NCT00216411 ↗

Phase 4 Completed 96 enrolled Ipsen
RandomizedParallel-groupDouble-blindTreatment

Summary

The main purpose of this study is to assess the effect on Quality of Life of two cycles of Dysport treatment on post-stroke spasticity of the upper limb. The effect of treatment on spasticity and function will also be measured.

Timeline

Start
2004-11
Primary completion
2006-07-20
Completion
2006-07-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 500 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 1000 iu Intramuscular

Indications